Compositions and methods for inducing thrombopoiesis
AssigneeHadasit Medical Research Services and Development Ltd.
InventorsDina Ben Yehuda, Ihab Abd-Elrahman, Riki Perlman, Marjorie Pick
Life of this patent
Estimating the term…
Loading patent…
AssigneeHadasit Medical Research Services and Development Ltd.
InventorsDina Ben Yehuda, Ihab Abd-Elrahman, Riki Perlman, Marjorie Pick
Estimating the term…
Methods of inducing thrombopoiesis and/or treating thrombocytopenia in a subject are provided. Accordingly there is provided a method comprising contacting stem cells with a differentiation potential towards platelets or hematopoietic progenitor cells derived therefrom with Livin, thereby inducing thrombopoiesis. Also provided is a method comprising contacting cells with a differentiation potential towards platelets with tLivin, thereby inducing thrombopoiesis. Also provided are compositions and isolated population of cells for inducing thrombopoiesis and/or treating thrombocytopenia in a subject.
A method of inducing thrombopoiesis, the method comprising contacting stem cells with a differentiation potential towards platelets, said cells being selected from the group consisting of embryonic stem cells (ESCs), induced pluripotent stem cells (iPS), hematopoietic stem cells and hematopoietic progenitor cells derived therefrom with a platelet production stimulating factor selected from the group consisting of thrombopoietin (TPO), TPO agonist, stem cell factor (SCF) and Phorbol myristate acetate (PMA);
A method of inducing thrombopoiesis, the method comprising contacting cells with a differentiation potential towards platelets with a platelet production stimulating factor selected from the group consisting of thrombopoietin (TPO), TPO agonist, stem cell factor (SCF) and Phorbol myristate acetate (PMA);
Dependencies are inferred from the claim text.